WuXi Biologics
Offering End-to-End Solutions
Company
Vision
& Mission
“Every drug can be made and every disease can be treated” by building an open-access platform with the most comprehensive capabilities and technologies in the global biologics industry
To accelerate and transform the discovery, development and manufacturing of biologics through a comprehensive open-access platform, enabling our global healthcare partners and benefiting patients worldwide
WuXi Biologics (stock code: 2269.HK) is a global leading Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop, and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.
With over 10,000 skilled employees in China, the United States, Ireland, Germany, and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development, and manufacturing solutions. As of April 30, 2022, WuXi Biologics is supporting over 526 integrated client projects, including nine in commercial manufacturing.
WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, further enhancing our commitment to sustainability.
projects in pre-clinical development stage
projects in early-phase clinical trials
projects in late-phase clinical trials
projects in commercial manufacturing
Culture
Integrity, Dedication, Working Together & Sharing Success
-
Put Customers First
Exceed customers’ expectations, maximize the value for our customers, and win customers’ loyalty with a 100% customer retention rate.
-
Demonstrate Integrity
Take the initiative to promote a positive work environment where doing the right thing is the standard. Be positive and enthusiastic, approach challenges with energy and optimism.
-
Strive for Excellence
Pursue focus and expertise, and optimize processes in order to deliver excellent results. Relentlessly drive learning, accumulation, improvement and innovation.
-
Execute for Results
Drive effective execution of each project and objective, focusing on solutions and results.
-
Pursue Collaboration and Teamwork
Engage in collaboration and mutual development with an open and win-win mindset by sharing resources and leveraging the complementary advantages of each.
-
Embrace Change and Drive Innovation
Demonstrate flexibility and ability to embrace change. Adapt quickly to transformational and innovative conditions with a strong commitment to breakthroughs and development.
History & Awards
Business Ethics & IP Policy
As a leading global open-access biologics technology platform, WuXi Biologics is committed to the highest standards of ethics and integrity. Employees, officers and directors strive to deal honestly, ethically and fairly with our suppliers, customers, competitors, employees and the communities we serve worldwide. Statements regarding the Company’s products and services must not be false, misleading, deceptive or fraudulent. WuXi Biologics strives to conduct business with individuals and organizations who share our commitment to highest ethical standards and who operate in a socially and environmentally responsible manner..
In line with that commitment, the Company expects and encourages its employees, customers, suppliers and other stakeholders who have concerns about any suspected misconduct or malpractice within the Company to come forward and voice those concerns through the whistleblowing channel. Compliance reporting: legal@wuxibiologics.com, IA_biologics@wuxibiologics.com，Compliance_Biologics@wuxibiologics.com
《Anti-Corruption Policy of WuXi Biologics》 《WHISTLEBLOWING AND INVESTIGATION》 《THE CONFLICT OF INTEREST POLICY》
《CODE OF BUSINESS CONDUCT AND ETHICS》 《CODE OF BUSINESS CONDUCT AND ETHICS of WuXi Biologics Business Partner》
“Our purpose in business is to enable innovation for our global partners, who keep us at the top of their confidence. IP is our shared lifeline. We guard it at WuXi Biologics with our founding principles of integrity, world-class security, zero tolerance policies, and relentless pursuit of justice against any criminal act. This is our highest priority, and we must hold ourselves accountable. We are determined to earn the trust of our partners by committing to success together.”
Intellectual Property Protection is the foundation of trust between WuXi Biologics and our global customers. To that end, we have established the most stringent policies in China and in U.S. for the protection of intellectual property and for prosecution of IP violations. We guard IP with founding principles of integrity, world-class security, zero-tolerance policy enforcement, and relentless pursuit of justice against any criminal act.
Environmental, Social and Governance
Pioneer and Promote Green Practices
Give Back to Community
WuXi Biologics Volunteer Association (China Region) Formed
WuXi Biologics Charity Foundation Donates RMB 10 Million to Flood Relief Efforts Across Henan, China
Bring Our Light of Hope to the Darkness
DEI trainings in the workplace: WuXi Biologics further fosters DEI and sustainability
the Wild Animal Friendly undertaking as a pharmaceutical enterprise
Improve Corporate Governance
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?